Coronado Biosciences Obtains $14,118,534 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=79f940c2-1426-4491-a4f9-ad307fd3be65&Preview=1
Date
1/20/2011
Company Name
Coronado Biosciences
Mailing Address
1700 7th Ave. Seattle, WA 98101
Company Description
Coronado Biosciences is a clinical stage biopharmaceutical company focused on making cancer care better. How do we define better? We hope to make cancer care safer and more easily tolerated with improved outcomes.
Website
http://www.CoronadoBioSciences.com
Transaction Type
Venture Equity
Transaction Amount
$14,118,534
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. Represents value of certain shares of the issuer’s preferred stock which were exchanged as consideration for the acquisition of certain assets. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed